HALYARD Laparoscopy Comprehensive Pack II REF: 49332 Recall
HALYARD Laparoscopy Comprehensive Pack II REF: 49332
FDA recall Class II
Ongoing
FDA lists this Class II recall for HALYARD Laparoscopy Comprehensive Pack II REF: 49332. Review the affected identifiers, reported reason and manufacturer instructions below.
Recall at a glance
- Recall number
- Z-0077-2027
- Recall classification
- Class II
- Enforcement status
- Ongoing
- Initiation date
- Aug 26, 2026
- FDA report date
- Oct 14, 2026
- Quantity in commerce
- 396 kits
- Distribution
- See key details
- FDA cause
- Labeling design
What is being recalled?
HALYARD Laparoscopy Comprehensive Pack II REF: 49332
Affected model & UDI checker
Search the exact identifiers published for Z-0077-2027.
The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.
Affected products
| Model / catalog number | Product | Lot scope reported | UDI / GTIN |
|---|---|---|---|
| 49332 | HALYARD Laparoscopy Comprehensive Pack II REF: 49332 | Check source notice | Not specified |
| Not specified | HALYARD Laparoscopy Comprehensive Pack II REF: 49332 | Check source notice | 10680651493320 |
FDA code information
UDI-DI: 10680651493320 (unit level), 30680651493324 (case level) Lot Numbers: GL25271CXA-Expiry Date: 2029/3/30; GL25296CXA-Expiry Date: 2029/3/30; GL26076CXA-Expiry Date: 2029/5/31
Why was this product recalled?
Laparoscopy packs labeled as "latex free" were found to contain a latex urethral catheter
What actions did GRI Medical & Electronic Technology Co., Ltd. take?
On August 26, 2026, GRI Medical & Electronics Technology Co., Ltd is a Urgent: Medical Device Recall Notification via Email to affected consignees. GRI ask consignees to take the following action: 1. Immediately segregate all affected product lots in a dedicated, clearly marked quarantine zone within your warehouse and all downstream hospital storage areas. Use prominent red labels stating RECALL DO NOT USE OR DISTRIBUTE to separate defective kits from compliant inventory. 2. Cease all outbound shipments, internal transfers and cross-facility redistribution of every lot of 49332 Laparoscopy Comprehensive Pack II. 3. Conduct a full physical inventory count of all recalled units on hand and document exact quantities per lot number for submission to GRI. 4. Share this notice with all staff who need awareness and any facility in which the affected product has been transferred to. 5. Within 3 business days customers are requested to complete and return the Recall Acknowledgment Form via the following official channels: Affairs team at RecallResponses@GRI-usa.com.
Read the manufacturer action recorded by FDARecall timeline
Recall initiated by firm
FDA notice posted
FDA classification recorded
FDA enforcement report date
Related FDA submissions
No submission number with an exact verified relationship is linked in the retrieved recall notice.
FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.
Source and update history
- FDA recall notice Z-0077-2027
- openFDA enforcement record · Source release Nov 11, 2026 · Retrieved Nov 19, 2026
- openFDA device recall record · Source release Nov 14, 2026 · Retrieved Nov 19, 2026
- FDA enforcement data
First stored snapshot of this source.
- FDA device-recall notice
First stored snapshot of this source.
The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.
Our data sources and methodology